 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
 |
Toronto, Ontario, Canada Bethesda, MD New York, NY Cincinnati,, OH Columbus, OH |
 |
04/21/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Randomized Phase III Study of Temozolomide and Short-Course Radiation Versus Short-Course Radiation Alone In The Treatment of Newly Diagnosed Glioblastoma Multiforme in Elderly Patients |
 |
Toronto, Ontario, Canada |
 |
08/26/2007 |
 |
 |
 |
Details |
 |
A Phase II Trial to Evaluate the Effect of Low Dose Temozolomide (TMZ) for 2 Weeks (Pre-Surgery) on Brain Tumor O-6-Methylguanine-DNA Methyltransferase (MGMT) Activity in Patients With Gliomas. |
 |
Montreal, Canada |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma |
 |
Toronto, Ontario, , Canada |
 |
05/21/2006 |
 |
 |
 |
Details |
 |
A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour |
 |
Edmonton, Alberta, Canada |
 |
05/04/2006 |
 |
 |
 |
 |
 |
Details |
 |
Comparative 2-D Tumor Analysis in Familial Gliomas |
 |
Edmonton, Alberta, Canada |
 |
05/04/2006 |
 |
 |
 |
Details |
 |
Multimodality Functional Imaging (MRS and Tumor Perfusion) Predicts Tumor Migration, Invasiveness, and Patterns of Failure of Human Gliobastoma Treated With Concurrent Radiation Therapy and Temozolomide |
 |
Edmonton, Alberta, Canada |
 |
11/27/2005 |
 |
 |
 |
 |
 |
Details |
 |
Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors |
 |
, Canada , Los Angeles, CA Palo Alto, CA Washington, DC Indianapolis, IN Boston, MA Minneapolis, MN Rochester, MN Jackson, MS New York, NY Syracuse, NY Cincinnati, OH Portland, OR Philadelphia, PA Pittsburgh, PA Memphis, TN Dallas, TX Houston, TX Seattle, WA |
 |
11/11/2005 |
 |
 |
 |